Visceral Leishmaniasis in a patient with common variable immunodeficiency and Evans syndrome: Clinical remarks

New Microbiologica

Volumn 32, Issue 2, 2009, Pages 223-227

  Maio, Patrizia ^a   Leone, Sebastiano ^a   Volpe, Silvestro ^a   Dell'Aquila, Giuseppina ^a   Giglio, Sergio ^a   Magliocca, Mario ^a   Nigro, Francesco Saverio ^a   Pacifico, Piera ^a   Acone, Nicola ^a  

^a S G MOSCATI HOSPITAL   (Italy)

Author keywords

Common variable immunodeficiency; Evans syndrome; FUO; Splenectomy; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIPROTOZOAL AGENT; GLUCOCORTICOID; PREDNISONE;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; COMMON VARIABLE IMMUNODEFICIENCY; FEVER; HUMAN; IMMUNE DEFICIENCY; MALE; MIDDLE AGED; PASSIVE IMMUNIZATION; PATHOPHYSIOLOGY; SPLENECTOMY; THROMBOCYTOPENIA; VISCERAL LEISHMANIASIS;

AMPHOTERICIN B; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIPROTOZOAL AGENTS; COMMON VARIABLE IMMUNODEFICIENCY; FEVER; GLUCOCORTICOIDS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOCOMPROMISED HOST; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; PREDNISONE; SPLENECTOMY; THROMBOCYTOPENIA;

EID: 67649994674     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. ANTINORI S., CASCIO A., PARRAVICINI C, BIANCHI R., CORBELLINO M. (2008). Leishmaniasis among organ transplant recipients. Lancet. Infect. Dis. 8, 191-199.
2. BADA J.L., ARDERIU A., GIMENEZ J., GUMEZ-ACHA J.A. (1979). Kala-azar of longlasting evolution in an as- plenic patient. Trans. R. Soc. Trop. Med. Hyg. 73, 347-348.
3. BASSET D., FARAUT F, MARTY P., DEREURE J., ROSENTHAL E., MARY C, PRATLONG E, LACHAUD L., BASTIENR, DEDET J.P (2005). Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Microbes. Infect. 7, 1370-1375.
4. BERMAN J.D. (1997). Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24, 684-703.
5. BERN C, RASHIDUL, H., CHOWDHURY R., ALI M., KURKJIAN K.M., VAZ L., AMANN J., WAHED M.A., WAGATSUMA Y., BREIMAN R.F., WILLIAMSON J., SECOR W.E., MAGUIRE J.H. (2007). The epidemiologicy of visceral leishmaniasis and asymptomatic leishmanial infection in a higly endemic bangladeshi village. Am. J. Trop. Med. Hyg. 76, 909-914
6. BOUMPAS D.T., CHROUSOS G.P., WILDER R.L., CUPPS T.R., BALOW J.E. (1993). Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann. Intern. Med. 119, 1198-1208.
7. CHAPEL H., LUCAS M., LEE M., BJORKANDER J., WEBSTER D., GRIMBACHER B., FIESCHI C, THON V., ABEDI M.R., HAMMARSTROM L. (2008). Common variable immunodeficiency disorders: division into distinct phenotypes. Blood. 111,4872-4878.
8. EVANS R.S., TAKAHASHI K., DUANE R.T., PAYNE R., LIU C. (1951). Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. Arch. Intern. Med. 87, 48-65.
9. FERNANDEZ-GUERRERO M.L., AGUADO, J.M., BUZON L., BARROS C, MONTALBAN C, MARTIN T., BOUZA E. (1987). Visceral leishmaniasis in immunocompromised hosts. Am. J. Med. 183, 1098-1102.
10. FERNANDEZ-GUERRERO M.L., ROBLES R, RIVAS R, MOJER E, MUNIZ G., DE GORGOLAS M. (2004). Visceral Leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta. Trop. 90, 11-16.
11. GARCIA-MUNOZ R., ANTON R., RODRIGUEZ-OTERO R, MORENO C, SANCIIEZ- IBARROLA A., SEIJO L.M., PARAMO J.A. (2008). Common variable immunodeficiency and Evans sindrome complicated by autoimmune hemolysis due to anti-Jka auto-antibodies. Leuk. Lymphoma. 22, 1-3.
12. GASIM S., THEANDER T.G., ELHASSAN A.M. (2000). High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis. Acta. Trop. 75, 35-38.
13. GOLDACKER S., DRAEGER R., WARNATZ K., HUZLY D., SALZER U., THIEL J., EIBEL H., SCHLESIER M., PETER H.H. (2007). Active vaccination in patients with common variable immunodeficiency (CVID). Clin. Immunol. 124, 294-303.
14. GRADONI L., GRAMOCCIA M., SCALONE A. (2003). Visceral Leishmaniasis Treatment, Italy. Emerg. Infect. Dis. 9, 1617-1620.
15. GRADONI L., PIZZUTI R., SCALONE A., RUSSO M., GRAMOCCIA M., DI MARTINO L., PEMPINELLO R., GAETA G.B. (1996). Recrudescence of visceral leishmaniasis unrelated to HIV infection in the Campania region of Italy. Trans. R. Soc. Trop. Med. Hyg. 90, 234- 245.
16. HERNANDEZ-PEREZ J., YEBRA-BANGO M., JIMENEZ- MARTINEZ E., SANZ- MORENO C, CUERVAS-MONS V, ALONSO PULPON L., RAMOS-MARTINEZ A., FERNANDEZ- FERNANDEZ J. (1999). Visceral leishmaniasis (kala- azar) in solid organ transplantation: report of five cases and review. Clin. Infect. Dis. 29, 918-921.
17. KEMP K. (2000). Cytokine-producing T cell subsets in human leishmaniasis. Arch. Immunol. Titer. Exp. 48, 173-176.
18. LOZANO E, TORRE CISNEROS J., BASCUNANA A., POLO J., VICIANA P., GARCIA-ORDONES M.A., HERNANDEZ- QUERO J., MARQUEZ M., VERGARA A., DIEZ F, PUJO E., TORRES TORTOSA M., PASQUAU J., HERNANDEZ- BURRUEZO J.J., SUAREZ I. (1996). Prospective evaluation of fever of unknow origin in patients infected with the human immunodeficiency virus. Eur. J. Clin. Microbiol. Infect. 15, 705-711.
19. MARTIN J.C., SANCHO T., SIERRA F.J., GARCIA PUIG J., LAVILLA P., JIMENEZ C, GIL A. (1996). Visceral leishmaniasis in a patient with hyper-IgM hypogammaglobulinemia. Clin. Infect. Dis. 23, 1188-1189.
20. MENDOZA H., ARDAIZ M.A., SANCHEZ-ALVAREZ J., GONI M.A. (1997). Leishmaniasis with hypogammaglobulinemia and its relationship with T-cell lymphoma. Enferni. Infecc. Microbiol. Clin. 15, 226-227.
21. MEYERHOFF A. (1999). U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin. Infect. Dis. 28, 42-48.
22. PASIC S., MINIC A., DJURIC P., MICIC D., KUZMANOVIC M., RARJANOVIC L., MARKOVIC M. (2006). Fever of unknown origin in 185 paediatric patients. A single- center experience. Acta. Paediatr. 95, 463-466.
23. PATI H.P., KASHYAP R., CHOUDRY V.P., MOHAPATRA M. (1999). Visceral leishmaniais: an opportunistic infection in haematological malignancy. Haematologia. 29, 295-300.
24. SALTOGLU N., TASOVA Y., MIDIKLI D., AKSU H.S., DUNDAR I.H. (2004). Fever of unknow origin in Turkey: evaluation of 87 cases during a nine-year-period of study. J. Infect. 48, 81-85.
25. SCHROEDER H.W., COOPER M.D. (2007). Immunodeficiency diseases. In: Lichtman M.A., Beutler E., Kipps T.J., Seligsohn U., Kaushansky K., Prchal J.T. (eds). Williams Hematology. McGraw-Hill, New York. 1099-1108.
26. SINGH U.K., PATWARI A.K., SINHA R.K., KUMAR R. (1999). Prognostic value of serum C-reactive protein in kala-azar. J. Trop. Pediatr. 45, 226-228.
27. STUCK A.E., MINDER C.E., FREY F.J. (1989). Risk of infectious complications in patients taking glucocor- ticosteroids. Rev. Infect. Dis. 11, 954-963.
28. VOUTSINAS D.,FOUDOULAKI L., SOFRONIADOU K., GALANAKIS N. (2001). Visceral leishmaniasis in a patient with acquired hypogammaglobulinemia. Eur. J. Intern. Med. 12, 127-129.
29. WANG J., CUNNINGHAM-RUNDLES C. (2005). Treatment and outcome on autoimmune hematologic disease in common variableimmunodeficiency/CVID). J. Autoimmun. 25, 57-62.
30. WORLD HEALTH ORGANIZATION. (1997). Leishmania/HIV co-infection. Epidemiological analysis of 692 retrospective cases. Wkty. Epidemiol. Rec. 72, 49-54.
31. WRIGHT J.J., BIRX D.L., WAGNER D.K., WALDMANN T.A., BLAESE R.M., FLEISHERT.A. (1987). Normalization of antibody responsiveness in a patient with common variable hypogammaglobulinemia and HIV infection. N. Engl. J. Med. 317, 1516-1520.
32. WRIGHT M.I. (1959). Kala-azar of unusual duration, associated with agammaglobulinaemia. Br. Med. J. 1, 1218-1221.